Becton, Dickinson and Company
BDX Healthcare Medical Instruments & Supplies
In the quarter to June 2026, revenue grew 5.44%, EPS fell 31.5%, free cash flow fell 31.6% and total debt fell 22.9%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for three.
Follow BDX
Becton, Dickinson and Company (BDX) Shares outstanding
Becton, Dickinson and Company's shares outstanding at the end of fiscal 2025 was $288.5M, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was $275.2M. Over the past ten years it has ranged from $207.5M (fiscal 2015) to $292.1M (fiscal 2021); the current reading is higher than 82% of that period. Becton, Dickinson and Company ranks 7th of 50 Medical Instruments & Supplies companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $288.5M | (0.86%) |
| FY2024 | $291.0M | 0.91% |
| FY2023 | $288.4M | 0.36% |
| FY2022 | $287.4M | (1.62%) |
| FY2021 | $292.1M | 3.43% |
| FY2020 | $282.4M | 2.78% |
| FY2019 | $274.8M | 3.84% |
| FY2018 | $264.6M | 18.35% |
| FY2017 | $223.6M | 2.78% |
| FY2016 | $217.5M | 4.83% |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Jun 2026 | $275.2M | (1.95%) |
| Mar 2026 | $280.6M | (1.82%) |
| Dec 2025 | $285.8M | (0.92%) |
| Sep 2025 | $288.5M | 0.45% |
| 42 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| MDLN Medline Inc. compare | $861.0M |
| BAX Baxter International Inc. compare | $518.0M |
| ALC Alcon compare | $488.7M |
| ISRG Intuitive Surgical, Inc. compare | $357.3M |
| BDX Becton, Dickinson and Company | $275.2M |
| SOLV Solventum Corporation compare | $173.3M |
| RMD ResMed Inc. compare | $146.1M |
| WST West Pharmaceutical Services, Inc. compare | $71.3M |
| RGEN Repligen Corporation compare | $56.6M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on BDX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement